Experts rate 12 vaccine claims by Robert Malone, the doctor catapulted to fame on Joe Rogan’s podcast Hilary Brueck, Andrew Dunn 17 feb 2022
Exclusive: Pfizer plans to start human studies of its Omicron-specific COVID-19 vaccine before the end of January Andrew Dunn 10 jan 2022
Premium These gene-editing startups are aiming to solve one of CRISPR’s biggest problems. Here’s how they could upend biotech in 2022 Andrew Dunn 29 dec 2021
The FDA just authorized the first pill to treat COVID-19, replenishing the toolkit of treatments against Omicron Andrew Dunn, Allison DeAngelis 22 dec 2021
Here’s the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered Andrew Dunn, Dr. Catherine Schuster-Bruce 10 dec 2021
The FDA says 16- and 17-year-olds can now get Pfizer’s COVID-19 vaccine booster shot Jake Epstein, Andrew Dunn 09 dec 2021
Omicron may challenge vaccine protection more than other variants, early lab data suggests, but the shots could still protect against severe disease Aria Bendix, Andrew Dunn 07 dec 2021
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns Andrew Dunn, Andrea Michelson 30 nov 2021
Pfizer’s top scientist Mikael Dolsten tells us the 2 factors that will determine if Omicron is a true threat and shares Pfizer’s worst-case-scenario plan Andrew Dunn 30 nov 2021
Omicron has drug companies preparing for the worst. Here are their plans to counterattack the newest COVID-19 variant. Andrew Dunn 29 nov 2021
